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Introduction and Objective: 
Preoperative anxiety has been shown to correlate with certain urinary symptoms in 
patients with certain types of voiding dysfunction, particularly overactive bladder. The 
purpose of this study was to evaluate if patient-reported anxiety correlates with 
pathologic characteristics, voiding symptoms, and objective metrics of bladder emptying in 
male patients undergoing holmium laser enucleation of the prostate (HoLEP). 
Patients and Methods: 
We began collecting patient-reported anxiety scores (GAD-7) in addition to patient-
reported scores of lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) 
starting in November 2018 for men with LUTS due to benign prostate hyperplasia. We 
retrospectively evaluated the relationship between preoperative GAD-7 score with 
preoperative age, BMI, preoperative urine flow metrics, preoperative post-void residual 
(PVR), and preoperative symptom scores for LUTS (AUA, BII, and MISI) and ED (SHIM and 
MSHQ-EjD). We then compared preoperative GAD-7 score to enucleated prostate weight, 
post-operative GAD-7 scores, post-operative urine flow metrics, post-operative PVR, and 
postoperative symptom scores for LUTS and ED.  
Results:  
We included 139 patients for analysis. The preoperative GAD-7 score positively correlated 
with preoperative BII scores (rs=0.202, p=0.019), MISI total (rs=0.260, p=0.002) and MISI 
bother (rs=0.345, p<0.001) scores. Preoperative GAD-7 negatively correlated with 
preoperative MSHQ-EJD (rs=-0.191, p=0.031). Following HoLEP, all four of these 
correlations disappear. The GAD-7 score did not correlate with age, BMI, preoperative 
urine flow metrics, preoperative PVR, or other preoperative LUTS and ED symptom scores. 
Additionally, preoperative GAD-7 score showed no correlation with enucleated prostate 
weight, postoperative urine flow metrics, postoperative PVR, and postoperative LUTS and 






































































































































































































































































Higher preoperative anxiety correlated with more severe pre-operative urinary LUTS, 
particularly incontinence symptoms, in patients undergoing HoLEP. Following HoLEP, these 








































































































































































































































































Anxiety is a common condition in the modern era, with up to 32% of adolescents 
and adults carrying some form of anxiety disorder1. Patients with anxiety and other mental 
health disorders also seek urologic care for conditions such as lower urinary tract 
symptoms (LUTS) and erectile dysfunction (ED), and these two seemingly unrelated body 
systems may actually contribute to each other’s disease processes2–4. In females, several 
studies have suggested that both depression and anxiety may specifically correlate with 
the diagnoses of overactive bladder (OAB) and urinary incontinence3,5–7. Male patients 
with depression and anxiety may similarly experience urinary storage symptoms more 
commonly than men without these diagnoses8,5. However, correlations to obstructive 
LUTS show variability within the literature8,9,10(p),11,12.   
The correlations between LUTS in men and mental health disorders do not 
immediately reveal whether one of these two disease categories may play a causative role 
in the etiology of the other13,14. Additionally, few studies exist demonstrating that 
treatment of one condition will simultaneously treat the other. At our institution, we have 
recognized that patient anxiety may play a role in how to optimally treat the offending 
symptoms and in health-related quality of life (HRQoL)11,15. As such, we have recently 
included routine evaluation of anxiety using the validated generalized anxiety disorder 7-
item (GAD-7)16 score in male patients seeking treatment for LUTS due to benign prostate 
hyperplasia (BPH). In the present study, we correlate patient anxiety with LUTS both 
before and after surgical treatment with holmium laser enucleation of the prostate 
(HoLEP).  
Materials and Methods: 
This study was approved by the institutional review board at Indiana University (# 
1902628723). Clinical data on patients at our institution undergoing HoLEP is prospectively 
collected in a REDCap database17. As part of our pre-operative clinical visit, we perform a 
detailed history and physical examination. In addition, we have patients complete a packet 
of validated symptom assessment tools regarding their voiding and sexual function. 




































































































































































































































































quality of life (IPSS QoL)18, the BPH impact index (BII)19, Michigan incontinence symptom 
index (MISI) total and bother scores20, sexual health inventory for men (SHIM)21, and the 
male sexual health questionnaire for ejaculatory dysfunction (MSHQ-EjD)22. Cumulatively, 
we refer to these symptom assessment tools as the symptom scores for LUTS and erectile 
dysfunction (ED). Beginning in November 2018, we incorporated the GAD-716 score into 
the packet of validated questionnaires. We also measure urine flow metrics (maximal and 
average urine flow) and post-void residual (PVR) bladder volume by ultrasound. 
Postoperatively, patients return to the office approximately 3 months from the date of 
surgery. At this time we obtain symptom scores for GAD-7, LUTS and ED, as well as urine 
flow metrics and a PVR. 
We included patients who had completed all of the symptom scores for LUTS and 
ED at both the pre-operative and the post-operative office visits, as well as a pre-operative 
GAD-7 score. Patients who did not return to our office for post-operative visits because 
they live too far away to return but mailed in the completed LUTS and ED symptom scores 
were also included. We correlated pre-operative GAD-7 scores with patient age, BMI, 
enucleated prostate weight, pre-operative and post-operative symptom scores for LUTS 
and ED, as well as preoperative and postoperative urine flow metrics and PVR values. 
Patients with indwelling catheters and therefore could not provide urine flow metrics or 
PVR did not have these specific variables included in the analysis, but their other data was 
included for analysis. We performed a sub-analysis comparing pre-operative and post-
operative individual symptom scores from the IPSS, as well as a sub-analysis correlating 
pre-operative GAD-7 scores with individual components of the IPSS.  
Of note, we did not exclude patients due to a past or present diagnosis of anxiety. 
Furthermore, we did we exclude patients currently or previously taking anxiolytics. We 
assessed anxiety as a continuous variable based on the GAD-7 score, given that it is a 
validated assessment of anxiety levels in all patients and would be the most up to date 








































































































































































































































































A complete description of the HoLEP procedure at our institution has been 
previously described23. Briefly, we use a 120 watt holmium:YAG laser (Pulse; Lumenis, Inc.) 
with a 550 or 1000 µm diameter laser fiber. We typically enucleate the median lobe first, 
and then perform a bottom-up approach.  
All statistical analysis was performed using IBM SPSS software, version 25 (Armonk, 
NY). Mean and standard deviation values were calculated for patient age, BMI, and 
enucleated prostate weight. We compared mean preoperative and postoperative GAD-7 
scores, symptom scores for LUTS and ED, urine flow metrics, and PVR using a two-tailed, 
paired Student’s t-test. Spearman’s correlation coefficient test was used to correlate pre-
operative GAD-7 scores with preoperative and postoperative symptom scores for LUTS and 
ED, as well as preoperative and postoperative urine flow metrics and PVR values. 
Significance was determined with a p-value less than 0.05.  
Results 
We included a total of 139 patients for analysis. The respective means (standard 
deviations) for age, BMI, and enucleated prostate weight among the group were 69 years 
(9 years), 28.7 kg/m2 (5.2 kg/m2), and 61 grams (50 grams). Forty-four (31.7%) patients had 
a preoperative GAD-7 score of 0, and 94 (67.6%) had scores in the minimal anxiety range 
of 0-416. Twenty-five (18.0%) patients had a GAD-7 score of 5-9 corresponding to mild 
anxiety, ten (7.2%) had scores in the moderate anxiety range of 10-14, and ten (7.2%) had 
scores of 15 or higher corresponding to severe anxiety. 
Table 1 compares mean preoperative and postoperative questionnaire scores, 
urine flow metrics, and PVR. The mean pre-operative GAD-7 score was 4, which 
postoperatively declined to 3 (p<0.001). The preoperative mean IPSS of 20 fell into the 
severely symptomatic range, but postoperatively this declined to 9 (moderately 
symptomatic range). Preoperative IPSS QoL scores also declined from a mean of 4 (mostly 
dissatisfied) to a mean of 2 (mostly satisfied) postoperatively. BII scores decreased from a 
mean of 7 preoperatively to 3 postoperatively. MISI total scores increased from 7 to 9 
postoperatively, while MISI bother scores remained stable at 2. SHIM scores remained 




































































































































































































































































showed significantly increased maximal flow rates postoperatively, although average flow 
rates were not significantly different. PVR did significantly decrease from postoperatively. 
Twenty-three patients (16.5%) were in urinary retention requiring an indwelling catheter 
or intermittent catheterization prior to surgery. Of these men in retention, their mean 
postoperative peak urine flow rate was 11.6 (SD 6.7) mL/second, their mean postoperative 
average urine flow rate was 5.2 (SD 3.1) mL/second, and their mean post-void residual was 
105 (SD 196) mL.  
Table 2 contains correlations between preoperative GAD-7 scores patient 
demographics, preoperative and postoperative LUTS and ED scores, preoperative and 
postoperative urine flow metrics and PVR, and enucleated prostate weight using 
Spearman’s correlation coefficient. The preoperative GAD-7 score positively correlated 
with preoperative BII scores (rs=0.202, p=0.019), MISI total (rs=0.260, p=0.002) and MISI 
bother (rs=0.345, p<0.001) scores, meaning a higher GAD-7 correlated with worse LUTS 
and worse incontinence. Preoperative GAD-7 negatively correlated with preoperative 
MSHQ-EJD (rs=-0.191, p=0.031), meaning the higher the GAD-7 the more severe the 
preoperative ejaculatory dysfunction. We observed no correlation with patient age, BMI, 
and enucleated prostate weight. Following HoLEP, these correlations disappeared. 
Additionally, we observed no correlation between preoperative GAD-7 and postoperative 
IPSS, IPSS QoL, SHIM, urine flow metrics, and PVR. Preoperative and postoperative GAD-7 
scores had a significantly positive correlation (rs=0.571, p<0.001), suggesting no change in 
patient-reported anxiety before and after surgery. 
A sub-analysis comparing mean pre-operative and post-operative individual 
symptom scores within the IPSS is presented in Supplementary Table 1. Mean symptom 
scores for all parameters were significantly higher preoperatively compared to 
postoperatively (all p<0.001). A sub-analysis correlating pre-operative GAD-7 to individual 
symptom scores within the IPSS, both pre-operatively and post-operatively, is presented in 
Supplementary Table 2. Pre-operative GAD-7 positively correlated with pre-operative 
urgency (rs=0.185, p<0.033), pre-operative straining (rs=0.173, p<0.048), and post-








































































































































































































































































We retrospectively evaluated patients undergoing HoLEP for LUTS due to enlarged 
prostate, and explored correlations between patient anxiety and preoperative and 
postoperative LUTS and ED. We observed that prior to HoLEP, higher patient anxiety 
positively correlated with more severe voiding symptoms including incontinence, as well 
as with worse preoperative ejaculatory dysfunction. We then observed that these 
correlations disappear postoperatively and those patients with a higher GAD-7 score could 
obtain the same surgical results as patients with lower GAD-7 scores.  In other words, 
preoperative anxiety may have resulted in worse voiding symptoms prior to surgery but 
did not affect the surgical outcome. Based on the dramatic improvement of LUTS following 
HoLEP in this series and others24, we can speculate that voiding symptoms would 
contribute less to a patient’s anxiety. The anxiety captured by the GAD-7 score was 
preserved postoperatively and occurs independent of LUTS based on the strong and 
positive correlation between preoperative and postoperative GAD-7. The symptoms that 
appear to be most impacted by anxiety are urgency, straining, and incontinence, as well as 
the overall effect of BPH on health (as measured by the BII).  
As surgical specialists, it is important to recognize that the urologic conditions for 
which our patients seek treatment may not exist in isolation from anxiety and other 
mental health disorders. As it pertains to the present study, the impact of LUTS on patient 
quality of life is especially important. Previously, a study from France assessed the change 
in both urinary symptoms and health-related quality of life (HRQoL), as measured with the 
EQ-5D score, as a response to medical treatment of LUTS13. Over a mean of 5.2 years, 
patient quality of life outcomes were overall quite disappointing. Worse IPSS quality of life 
scores were reported by 42% of patients, and patients with moderate-to-severe LUTS had 
altered HRQoL scores in all five parameters of the EQ-5D. Similarly, Yang et al25 found that 
patients with anxiety and BPH more commonly had no response of their IPSS QoL scores 
when treated medically for BPH. Taken together, these may suggest that medical 
treatment of LUTS due to BPH in patients with anxiety may poorly respond to medical 
therapies in terms of urinary quality of life. Looking more broadly at the impact of LUTS on 




































































































































































































































































patient-reported OAB and LUTS in a survey-based study of over 8,000 patients in China, 
Taiwan, and South Korea. Interestingly, patients with LUTS also reported lower workplace 
productivity, presumably due to the burdens associated with their disease. Our study did 
not find a correlation with the IPSS quality of life score, but did see a positive correlation 
with BII. Our patient population that is ready for surgical management typically has high 
preoperative IPSS and IPSS QoL scores for the entire population, which may explain why 
there was no correlation with preoperative GAD-7. Similar to these aforementioned 
studies of HRQoL, the BII asks the patient to think about voiding in the context of his entire 
health. Our positive correlation between BII and GAD-7 scores appears to fit with the data 
from those other studies of HRQoL such that patients with higher anxiety may experience 
more concern over how their voiding symptoms affect their overall health. 
As reviewed above, prior authors have observed that patient incontinence and OAB 
symptoms correlate positively with patient anxiety in both female and male patients. The 
reason for this association remains unclear. Lai et al26 compared male and female patients 
with OAB to a matched cohort of patients without OAB, and found that patients with OAB 
reported more systemic (i.e. non-urological) symptoms. The authors suggested that 
perhaps there exist systemic factors contributing to both the LUTS and the non-urological 
symptoms. The correlation between LUTS and systemic factors has been explored by 
Martin et al8, who measured serum inflammatory marker levels in patients with LUTS and 
coexistent depression and/or anxiety, albeit with inconclusive results. Others have 
suggested that perhaps there is a psychogenic component27. In particular, patients with 
psychogenic urinary dysfunction may experience transient or situational urodynamic 
findings consistent with OAB or other symptoms28.  
Of particular importance, patient-reported incontinence on the MISI scores 
preoperatively held an association with anxiety, but this association was lost following 
HoLEP. Meaning, patients with anxiety were not likely to experience more severe 
postoperative incontinence. A prior study by Felde et al6 suggested that both depression 
and anxiety are independent risk factors for incontinence in a large Norwegian female 
cohort of over 16,000 patients. Interestingly, they observed the anxiety association with 




































































































































































































































































directly comparable to BPH in men, there may be some overlap in the incontinence 
pathways common to both sexes. One element of preoperative incontinence in our male 
cohort is the element of post-void dribbling, which anecdotally many of our patients 
categorize as incontinence and for which they will wear pads. While this type of 
incontinence may differ from stress or urge incontinence, it is still a bothersome symptom 
for patients causing them to seek treatment. The results of our present study would 
support that the character of incontinence preoperative and postoperatively may be 
different, and the experience of incontinence to the patient may be different depending 
on patient anxiety levels.  
Contrary to our suspicions, prostate size did not correlate with anxiety. Given the 
positive correlation between LUTS and anxiety, we suspected that patients with higher 
levels of anxiety may experience bothersome LUTS earlier in the disease process of benign 
prostate growth, i.e. while the prostate is still relatively small. As our data demonstrates, 
this correlation did not exist. The lack of association suggests that the LUTS must develop 
independent of anxiety. While the severity of LUTS as measured by validated (and 
numerical) symptom scores may be more pronounced in men with anxiety, the biologic 
phenomenon of benign prostate hyperplasia must occur for men to experience obstructive 
LUTS related to this condition. This would suggest that anxiety independently does not 
play a causative role in LUTS, but rather correlates with a more severe patient experience 
of LUTS. This may be important when assessing patients both at the initial encounter and 
in follow-up, as these patients may benefit from a more frequent or aggressive 
management strategy to control their symptoms. 
Our study does have certain limitations. First, it is the retrospective nature of our 
analysis; however, all data is prospectively maintained in a dedicated database that is 
updated weekly. Second, our assessment of patient anxiety relies upon patients accurately 
and truthfully completing these validated questionnaires. It is possible that patients may 
underreport anxiety if they are reluctant to complete the anxiety questionnaires 
accurately for any reason such mental health disease stigma or desire to focus solely on 
the urologic issue at hand. Third, we are a tertiary referral center for HoLEP and often see 







































































































































































































































































intervention. Our cohort assessed patients ready for a surgical intervention, and we did 
not assess correlations of anxiety, LUTS, and ED at earlier stages in the disease process 
when a less-invasive intervention such as initiation of or change in medication would be 
offered. Similarly, we did not evaluate other surgical treatments for LUTS due to BPH. 
Additionally, this is a male cohort treated for BPH, which is one of many etiologies of LUTS. 
Consequently, we did not assess the response to other surgical interventions for different 
causes of LUTS such as those experienced in a female population.  Fourth, since we are a 
tertiary referral center the outcomes may be biased towards patients who are 
experiencing a prolonged recovery after surgery. In general, patients that are pleased with 
their results are more likely to cancel their 3 month appointment while those that are still 
in the recovery process tend to keep the appointment. The follow up confounder most 
likely accounts for the higher MISI score at 3 month follow up.  We tried to correct for this 
confounding factor by mailing the questionnaires to patients who did not keep their follow 
up appointments.  Fifth, the GAD-7 score is a tool to independently assess anxiety, but not 
assess anxiety as it relates to voiding symptoms. This is demonstrated by the strong 
positive correlation seen between preoperative and postoperative GAD-7 scores in Table 
2. An interesting future study could assess anxiety as it relates specifically to voiding 
symptoms, and assess if intervention for LUTS improves this disease-related anxiety. 
Despite these limitations this study demonstrates that surgical intervention can improve 
LUTs secondary to BPH even in patients with significant preoperative anxiety. 
Conclusions 
Higher preoperative anxiety positively correlated with more severe preoperative 
LUTS and ejaculatory dysfunction. Following HoLEP, these associations disappear in spite 
of anxiety levels remaining similar, many LUTS scores improving, and ejaculatory 
dysfunction being similar. Thus, patients with anxiety and LUTs will likely have worse 
preoperative symptoms compared to patients without anxiety, but they can expect to 
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BII = Benign prostate hyperplasia impact index 
BPH = Benign prostate hyperplasia 
ED = Erectile dysfunction 
HoLEP = Holmium laser enucleation of the prostate 
HRQoL = Health related quality of life 
GAD-7 = Generalized anxiety disorder 7-item 
IPSS = International prostate symptom core 
IPSS QoL = International prostate symptom score quality of life 
LUTS = Lower urinary tract symptoms 
MISI = Michigan incontinence symptom index 
MSHQ-EjD = Male sexual health questionnaire for ejaculatory dysfunction 
OAB = Overactive bladder 
PVR = Post-void residual 




































































































































































































































































Table 1. Comparison of preoperative and postoperative GAD-7 score, LUTS scores, ED 
scores, urine flow metrics, and PVR. 
Preoperative Postoperative p-value
Mean (SD) GAD-7 4 (5) 3 (4) <0.001 
Mean (SD) IPSS 20 (8) 9 (7) <0.001 
Mean (SD) IPSS QoL 4 (1) 2 (2) <0.001 
Mean (SD) BII 7 (3) 3 (3) <0.001 
Mean (SD) MISI 
Total 
7 (6) 9 (8) 0.007 
Mean (SD) MISI 
Bother 
2 (2) 2 (3) 0.588 
Mean (SD) SHIM 10 (9) 10 (9) 0.683 
Mean (SD) MSHQ-
EJD 
8 (6) 6 (4) 0.001 
Mean (SD) Maximal 
Urine Flow Rate in 
Milliliters/Second 
7.9 (4.6) 17.1 (10.4) <0.001 
Mean (SD) Average 
Urine Flow Rate in 
Milliliters/Second 
4.6 (8.5) 10.0 (18.8) 0.104 
Mean (SD) Post-void 
Residual in 
Milliliters 




































































































































































































































































Table 2. Correlations between Preoperative GAD-7 Score and Patient Characteristics 
Patient Characteristic Spearman’s Correlation Coefficient p-value
Age (Years) -0.053 0.534 
BMI 0.017 0.841 
Preop IPSS Total 0.167 0.051 
Preop IPSS QoL 0.012 0.892 
Preop BII 0.202 0.019 
Preop MISI Total 0.260 0.002 
Preop MISI Bother 0.345 <0.001 
Preop SHIM -0.122 0.158 
Preop MSHQ-EJD -0.191 0.031 
Preop Maximal Urine Flow 
Rate 
-0.076 0.572 
Preop Average Urine Flow 
Rate 
0.020 0.885 
Preop Post Void Residual -0.094 0.466 
Enucleated Prostate Weight -0.097 0.257 
Postop GAD-7 0.571 <0.001 
Postop IPSS Total 0.100 0.248 
Postop IPSS QoL -0.096 0.277 







































































































































































































































































Postop MISI Total 0.079 0.365 
Postop MISI Bother 0.009 0.914 
Postop SHIM -0.130 0.147 
Postop MSHQ-EJD -0.001 0.991 
Postop Maximal Urine Flow 
Rate 
0.168 0.146 
Postop Average Urine Flow 
Rate 
0.065 0.581 






































































































































































































































































Supplementary Table 1. Comparison of preoperative and postoperative individual 
symptom scores within the IPSS. 
Preoperative Postoperative p-value
Mean (SD) Incomplete Bladder 
Emptying 
2.9 (1.81) 1.0 (1.5) <0.001 
Mean (SD) Frequency 3.5 (1.5) 2.0 (1.7) <0.001 
Mean (SD) Intermittency 2.9 (1.7) 0.8 (1.3) <0.001 
Mean (SD) Urgency 2.8 (1.7) 1.7 (1.7) <0.001 
Mean (SD) Weak Stream 3.3 (1.7) 0.7 (1.3) <0.001 




































































































































































































































































Supplemental Table 2. Sub-analysis of correlations between preoperative GAD-7 Score 
and individual symptom scores within the IPSS. 
Patient Characteristic Spearman’s Correlation Coefficient p-value
Preop Incomplete Bladder 
Emptying 
0.152 0.081 
Preop Frequency 0.131 0.134 
Preop Intermittency 0.030 0.733 
Preop Urgency 0.185 0.033 
Preop Weak Stream 0.077 0.376 
Preop Straining 0.173 0.048 
Preop Nocturia 0.158 0.071 
Postop Incomplete Bladder 
Emptying 
0.086 0.397 
Postop Frequency 0.171 0.090 
Postop Intermittency 0.027 0.789 
Postop Urgency 0.201 0.045 
Postop Weak Stream -0.108 0.285 
Postop Straining 0.031 0.759 
Postop Nocturia 0.049 0.629 
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